Warning: main(lemberg381/tools.php) [function.main]: failed to open stream: No such file or directory in /home/u7802/anti-aging-guide.com/www/products/rhodiola_3.php on line 2
Warning: main() [function.include]: Failed opening 'lemberg381/tools.php' for inclusion (include_path='.:/usr/local/share/pear') in /home/u7802/anti-aging-guide.com/www/products/rhodiola_3.php on line 2 Rhodiola. Anti-Aging-Guide -- Your plan to stay young
RHODIOLA
UPDATES
PRODUCTS
LIST
Int J Sport Nutr Exerc
Metab. 2004 Jun;14(3):298-307. Acute Rhodiola rosea intake can improve
endurance exercise performance.
De Bock K, Eijnde BO, Ramaekers M, Hespel P.
Faculty of Physical Education and Physiotherapy in the Exercise
Physiology and Biomechanics Laboratory at the Katholieke Universiteit
Leuven, Tervuursevest 101, B-3001 Leuven, Belgium.
PURPOSE: The purpose of this study was to investigate the effect
of acute and 4-week Rhodiola rosea intake on physical capacity,
muscle strength, speed of limb movement, reaction time, and attention.
METHODS: PHASE I: A double blind placebo-controlled randomized study
(n= 24) was performed, consisting of 2 sessions (2 days per session).
Day 1: One hour after acute Rhodiola rosea intake (R, 200-mg Rhodiola
rosea extract containing 3% rosavin + 1% salidroside plus 500 mg
starch) or placebo (P, 700 mg starch) speed of limb movement (plate
tapping test), aural and visual reaction time, and the ability to
sustain attention (Fepsy Vigilance test) were assessed. Day 2: Following
the same intake procedure as on day 1, maximal isometric knee-extension
torque and endurance exercise capacity were tested. Following a
5-day washout period, the experimental procedure was repeated, with
the treatment regimens being switched between groups (session 2).
PHASE II: A double blind placebo-controlled study (n = 12) was performed.
Subjects underwent sessions 3 and 4, identical to Phase I, separated
by a 4-week R/P intake, during which subjects ingested 200 mg R/P
per day. RESULTS: PHASE I: Compared with P, acute R intake in Phase
I increased (p <.05) time to exhaustion from 16.8 +/- 0.7 min
to 17.2+/- 0.8 min. Accordingly, VO2peak (p <.05) and VCO2peak
(p<.05) increased during R compared to P from 50.9 +/- 1.8 ml
x min(-1) x kg(- )1 to 52.9 +/- 2.7 ml x min(-10) x kg(-1) (VO2peak)
and from 60.0 +/- 2.3 ml x min(-1) x kg(-1) to 63.5+/- 2.7 ml x
min(-1) x kg(-1) (VCO2peak). Pulmonary ventilation (p =.07) tended
to increase more during R than during P (P: 115.9+/- 7.7 L/min;
R: 124.8 +/- 7.7 L/min). All other parameters remained unchanged.
PHASE II: Four-week R intake did not alter any of the variables
measured. CONCLUSION: Acute Rhodiola rosea intake can improve endurance
exercise capacity in young healthy volunteers. This response was
not altered by prior daily 4-week Rhodiola intake.
Medicina (Kaunas). 2004;40(7):614-9. Experimental analysis of therapeutic properties
of Rhodiola rosea L. and its possible application in medicine.
Kucinskaite A, Briedis V, Savickas A.
Department of Pharmaceutical Technology and Pharmacy Organization,
Kaunas University of Medicine, A. Mickeviciaus 9, 44307 Kaunas,
Lithuania.
The paper presents a review of the scientific publications on
Rhodiola rosea L. known for its adaptogenic characteristics. Biologically
active substances salidroside, rosin, rosavin, rosarin and tyrosol,
which are mainly found in plant rhizomes, demonstrate therapeutic
effect. These active components effect the central nervous system
by increasing the ability to concentrate, the mental and physical
power; they are efficient in the asthenic states and improve general
resistance of the cells and the organism against the harmful outer
influence. They also prevent the heart system from stress and
arrhythmias, and posses some antioxidant activity. Some data confirm
that the Rhodiola rosea L. preparations stop the growth of the
malignant tumors and metastases in the liver. Some preclinical
and clinical data of the golden root preparations are discussed
in the survey. The interaction of the herb with other medicines,
its usage and effect, recommended doses, and its side effects
are also reviewed in the paper.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2003 Sep;23(9):648-50.
Preventive and treatment effect of composite
Rhodiolae on acute lung injury in patients with severe pulmonary
hypertension during extracorporeal circulation.
Xu KJ, Zhang SF, Li QX.
Department of Cardio-thoracic Surgery, General Hospital of Lanzhou
Military Region of PLA, Lanzhou 730050.
OBJECTIVE: To investigate the possibility of early prevention
and treatment of acute lung injury by using composite Rhodiolae
(CR) in patients with severe pulmonary hypertension during extracorporeal
circulation. METHODS: Seventy-six patients with severe pulmonary
hypertension screened out by color 2D-Doppler ultrasonography
were randomly divided into the treated group (n = 40) and the
control group (n = 36). The general treatment for the two groups,
including preoperational preparation, operational procedure and
conventional drug therapy, was the same. To the treated group,
CR was administered 4 g every day (half the dose in children)
at 7-10 day before and 5-7 day after the operation. The life signs,
pulmonary ventilation parameters, arterial blood gas analysis
were monitored and blood levels of TXB2, 6-keto-PGF1 alpha in
both groups were determined in the fixed time points. RESULTS:
The various parameters in the treated group were all better than
those in the control group (P < 0.05 or P < 0.01), the occurrence
rate of acute lung injury and its mortality in the treated group
were 7.5% (3/40) and 0% (0/3) respectively, while in the control
group were 19.4% (7/36) and 43% (3/7) respectively. CONCLUSION:
CR has good preventive and treatment effect in treating complicated
acute lung injury during extracorporeal circulation (cardiopulmonary
bypass) in patients with pulmonary hypertension.
Phytomedicine. 2003 Mar;10(2-3):95-105. A randomized trial of two different doses
of a SHR-5 Rhodiola rosea extract versus placebo and control of
capacity for mental work.
Shevtsov VA, Zholus BI, Shervarly VI, Volskij VB, Korovin YP,
Khristich MP, Roslyakova NA, Wikman G.
Centre of Sanitary and Epidemiological Inspection of the R.F.
Ministry of Health, Moscow, Russia.
A randomized, double-blind, placebo-controlled, parallel-group
clinical study with an extra non-treatment group was performed
to measure the effect of a single dose of standardized SHR-5 Rhodiola
rosea extract on capacity for mental work against a background
of fatigue and stress. An additional objective was to investigate
a possible difference between two doses, one dose being chosen
as the standard mean dose in accordance with well-established
medicinal use as a psychostimulant/adaptogen, the other dose being
50% higher. Some physiological parameters, e.g. pulse rate, systolic
and diastolic blood pressure, were also measured. The study was
carried out on a highly uniform population comprising 161 cadets
aged from 19 to 21 years. All groups were found to have very similar
initial data, with no significant difference with regard to any
parameter. The study showed a pronounced antifatigue effect reflected
in an antifatigue index defined as a ratio called AFI. The verum
groups had AFI mean values of 1.0385 and 1.0195, 2 and 3 capsules
respectively, whilst the figure for the placebo group was 0.9046.
This was statistically highly significant (p < 0.001) for both
doses (verum groups), whilst no significant difference between
the two dosage groups was observed. There was a possible trend
in favour of the lower dose in the psychometric tests. No such
trend was found in the physiological tests.
J Ethnopharmacol. 2003 Feb;84(2-3):143-8. Protective effect of Rhodiola sachalinensis
extract on carbon tetrachloride-induced liver injury in rats.
Nan JX, Jiang YZ, Park EJ, Ko G, Kim YC, Sohn DH.
Department of Pharmacy, Wonkwang University, Iksan, Jeonbuk 570-749,
Republic of Korea.
This study was carried out to investigate the protective effect
of an aqueous extract from the root of Rhodiola sachalinensis
(RSE) on liver injury induced by repetitive administration of
carbon tetrachloride in rats. RSE was given orally to rats at
doses of 50, 100 or 200 mg/kg throughout the carbon tetrachloride
treatment for 28 days. In rats treated with carbon tetrachloride,
the levels of hydroxyproline and malondialdehyde (MDA) in the
liver, and serum enzyme activities were significantly increased.
RSE treatment significantly reduced the levels of liver hydroxyproline
and MDA, and serum enzyme activities, in accordance with improved
histological findings. Immunohistological findings indicated RSE
treatment inhibited hepatic stellate cell activation, which is
a major step for collagen accumulation during liver injury. These
data suggest that RSE protects the liver from repetitive injury
induced by carbon tetrachloride in rats.
Eksp Klin Farmakol. 2002 Nov-Dec;65(6):57-9.
Hepatoprotective properties of liquid extract
of Rhodiola rosea.
Iaremii IN, Grigoreva NF.
Medical Chemistry Department, Bukovinian State Medical Academy,
vul. Bohomoltsya 2, Chernivtsi 58000, Ukraine.
The effect of a liquid extract from Rhodiola rosea on the functional
state of rat liver with experimental toxic hepatitis was studied.
The extract produces a hepatoprotective effect, as manifested
by normalized activity of aspartate aminotransferase and alkaline
phosphatase, normalized content of medium-molecular-weight peptides,
urea, and bilirubin, and reduced activity of alanine aminotransferase
and glutathione-S-transferase in the blood plasma of rats with
the toxic hepatitis model.
Eksp Klin Farmakol. 2002 Jul-Aug;65(4):19-22.
Rhodiola rosea extract for prophylaxis of
ischemic cerebral circulation disorder.
Pogorelyi VE, Makarova LM.
Pharmacology Department, State Pharmaceutical Academy, Pyatigorsk,
pr. Kalinina 11, 357532 Russia.
It was experimentally established that prophylactic introduction
of a Rhodiola Rosea extract prevents the ischemic brain damage
development. A course administration of the drug in a dose of
700 mg/kg arrests the development of hyper- and hypoperfusion
in cerebral circulation, weakens the postischemic hyperglycemic
reaction, lowers oxygen extraction by cerebral tissues, suppresses
lactate acidosis, promotes pyruvate participation in metabolic
processes inhibits edema swelling, prevents the "calcium
paradox" development, and decreases manifestations of the
lipid peroxidation processes.
Zhonghua Jie He He Hu Xi Za Zhi. 2002 Sep;25(9):527-30.
The effect of rhodiola and acetazolamide
on the sleep architecture and blood oxygen saturation in men living
at high altitude.
Ha Z, Zhu Y, Zhang X, Cui J, Zhang S, Ma Y, Wang W, Jian X.
The 18th Hospital of PLA, Yecheng 844900, China.
OBJECTIVE: To study the changes of sleep architecture and blood
oxygen saturation (SaO(2)) during sleep in men living at high
altitude, and to investigate the effect of rhodiola and acetazolamide
on these sleep indexes. METHODS: Twenty-four men aged 18 to 21
years who had stayed at high altitude (5 380 m above sea level)
for 1 year were randomly divided into groups A (treated with oral
rhodiola), B (treated with oral acetazolamide) and C (treated
with rhodiola + acetazolamide). Their sleep architecture and SaO(2)
were recorded for 24 days before and after taking the medicines.
RESULTS: Compared with baseline, the waking SaO(2) (WSaO(2)),
the lowest SaO(2) (LSaO(2)) and the mean SaO(2) (MSaO(2)) were
increased significantly after treatment for 24 days (P < 0.01),
and the times of oxygen desaturation >/= 4% per hour (DI4)
and the percentage of time spent at SaO(2) below 80% (SIT(80))
were decreased significantly (P < 0.01). After treatment, the
NREM I and II was shortened, and III + IV and REM sleep were prolonged
(P < 0.01): the total waking time (TWT) was shortened, and
the sleep efficiency index (SEI) was markedly increased (P <
0.01). Compared with group A's, groups B's and C's SIT(80) were
increased (P < 0.05). CONCLUSION: Both rhodiola and acetazolamide
were effective in modulating the sleep architecture and improving
the sleep quality in young men living at high altitude, but there
was no synergistic effect between rhodiola and acetazolamide.
Phytother Res. 2002 Aug;16(5):467-73. In vitro antioxidant activity of non-cultivated
vegetables of ethnic Albanians in southern Italy.
Pieroni A, Janiak V, Durr CM, Ludeke S, Trachsel E, Heinrich M.
Centre for Pharmacognosy and Phytotherapy, The School of Pharmacy,
University of London, 29-39 Brunswick Square, London WC1N 1AX,
UK.
A total of 27 extracts from non-cultivated and weedy vegetables
traditionally consumed by ethnic Albanians (Arbereshe) in the
Vulture area (southern Italy) were tested for their free radical
scavenging activity (FRSA) in the DPPH (1,1-diphenyl-2-picrylhydrazil
radical) screening assay, for their in vitro non-enzymatic inhibition
of bovine brain lipid peroxidation and for their inhibition of
xanthine oxidase (XO). In both antioxidant assays strong activity
was shown for Leopoldia comosa (bulbs, syn.: Muscari comosum)
and Centaurea calcitrapa (young whorls). In the lipid peroxidation
assay, extracts from leaves of Origanum heracleoticum, Urtica
dioica and Tordylium apulum showed a remarkable inhibitory activity
(> 50%), too. In the case of Leopoldia comosa and Origanum
heracleoticum this activity was comparable to quercetin (at a
concentration of 50 microM) and Rhodiola rosea extract. Extracts
from non-cultivated Cichorium intybus, Chondrilla juncea and Stellaria
media showed strong in vitro inhibition of xanthine oxidase, with
an activity higher than that of a reference extract from Ledum
groenlandicum. These findings suggest that weedy vegetables may
be useful antioxidants of interest in the prevention of ageing
related diseases, CNS disorders and as potential sources of phytomedicines
against hyperuricaemia and gout.
Biol Pharm Bull. 2002 Aug;25(8):1101-4. Neuroprotective effects of constituents
of the oriental crude drugs, Rhodiola sacra, R. sachalinensis
and Tokaku-joki-to, against beta-amyloid toxicity, oxidative stress
and apoptosis.
Mook-Jung I, Kim H, Fan W, Tezuka Y, Kadota S, Nishijo H, Jung
MW.
Brain Disease Research Center, Ajou University School of Medicine,
Suwon, Korea.
We tested the constituents of two Rhodiola plants, Rhodiola sacra
S. H. Fu and R. sachalinensis A. BOR, and an Oriental crude drug,
Tokaku-joki-to, for their neuroprotective effects. Of the 58 compounds
tested, six had considerable protective effects against beta-amyloid-induced
death of B103 neuronal cells in vitro. These six compounds also
showed protective effects against staurosporine-induced cell death,
and two of the six compounds protected neurons from H2O2-induced
cell death. These results suggest that some of the tested compounds
protect neurons from beta-amyloid toxicity based on antiapoptotic
and antioxidative activity.
JOP. 2001 Jan;2(1):16-25. Association of free radicals and the tissue
renin-angiotensin system: prospective effects of Rhodiola, a genus
of Chinese herb, on hypoxia-induced pancreatic injury.
Ip SP, Che CT, Leung PS.
School of Chinese Medicine, Department of Physiology, The Chinese
University of Hong Kong, Shatin, N.T., Hong Kong.
The renin-angiotensin system has long been recognized as crucial
factor in the regulation of the systemic blood pressure and renal
electrolyte homeostasis. Numerous studies have demonstrated the
presence of a local renin-angiotensin system in a variety of organs.
A recent study of the pancreatic renin-angiotensin system showed
that chronic hypoxia significantly increased the mRNA expression
for angiotensinogen II receptor subtypes AT1b and AT2. The activation
of the renin-angiotensin system may play an important role in
cellular pathophysiological processes. Angiotensin II enhances
the formation of reactive oxygen species via the activation of
xanthine oxidase or NAD(P)H oxidase. The reactive oxygen species
can cause oxidative damage in the pancreas and other tissues either
directly or indirectly via the formation of other radicals such
as reactive nitrogen species. Rhodiola therapy may protect hypoxia-induced
pancreatic injury in two ways. It prevents hypoxia-induced biological
changes by increasing intracellular oxygen diffusion and efficiency
of oxygen utilization. Alternatively, it reduces hypoxia-induced
oxidative damage by its antioxidant activities. Additional experimental
data are required to fully elucidate the mode of action of this
herbal drug.
Altern Med Rev. 2001 Jun;6(3):293-302. Rhodiola rosea: a possible plant adaptogen.
Kelly GS.
Rhodiola rosea is a popular plant in traditional medical systems
in Eastern Europe and Asian with a reputation for stimulating
the nervous system, decreasing depression, enhancing work performance,
eliminating fatigue, and preventing high altitude sickness. Rhodiola
rosea has been categorized as an adaptogen by Russian researchers
due to its observed ability to increase resistance to a variety
of chemical, biological, and physical stressors. Its claimed benefits
include antidepressant, anticancer, cardioprotective, and central
nervous system enhancement. Research also indicates great utility
in asthenic conditions (decline in work performance, sleep difficulties,
poor appetite, irritability, hypertension, headaches, and fatigue)
developing subsequent to intense physical or intellectual strain.
The adaptogenic, cardiopulmonary protective, and central nervous
system activities of Rhodiola rosea have been attributed primarily
to its ability to influence levels and activity of monoamines
and opioid peptides such as beta-endorphins.
Eksp Klin Farmakol. 2000 Sep-Oct;63(5):59-61.
Medicinal plant preparations used as adjuvant
therapeutics in experimental oncology.
Razina TG, Zueva EP, Amosova EN, Krylova SG.
Tomsk Scientific Center, Siberian Division, Russian Academy of
Medical Sciences, Russia.
Experiments on mice inoculated with metastasing Lewis lung carcinoma
showed that the antitumor and antimetastatic effects of cyclophosphan
(cyclophosphamide) are potentiated by the extracts of phytopreparations
based on Baikal scullcap (Scutellaria baikalensis), rhodiola (Rhodiola
rosea), common licorice (Glycyrrhiza glabra), and their principal
acting components--baikalin, paratyrosol, and glycyrram.
Phytomedicine. 2000 Oct;7(5):365-71. Rhodiola rosea in stress induced fatigue--a
double blind cross-over study of a standardized extract SHR-5
with a repeated low-dose regimen on the mental performance of
healthy physicians during night duty.
Darbinyan V, Kteyan A, Panossian A, Gabrielian E, Wikman G, Wagner
H.
Department of Neurology, Armenian State Medical University, Yerevan.
The aim of this study was to investigate the effect of repeated
low-dose treatment with a standardized extract SHR/5 of rhizome
Rhodiola rosea L, (RRE) on fatigue during night duty among a group
of 56 young, healthy physicians. The effect was measured as total
mental performance calculated as Fatigue Index. The tests chosen
reflect an overall level of mental fatigue, involving complex
perceptive and cognitive cerebral functions, such as associative
thinking, short-term memory, calculation and ability of concentration,
and speed of audio-visual perception. These parameters were tested
before and after night duty during three periods of two weeks
each: a) a test period of one RRE/placebo tablet daily, b) a washout
period and c) a third period of one placebo/RRE tablet daily,
in a double-blind cross-over trial. The perceptive and cognitive
cerebral functions mentioned above were investigated using 5 different
tests. A statistically significant improvement in these tests
was observed in the treatment group (RRE) during the first two
weeks period. No side-effects were reported for either treatment
noted. These results suggest that RRE can reduce general fatigue
under certain stressful conditions.
Arch Pharm Res. 2000 Oct;23(5):455-8. Antioxidative phenolic compounds from the
roots of Rhodiola sachalinensis A. Bor.
Lee MW, Lee YA, Park HM, Toh SH, Lee EJ, Jang HD, Kim YH.
College of Pharmacy, Chung Ang University, Seoul, Korea.
The acetone extract of the roots of Rhodiola sachalinensis has
furnished six phenolic compounds which exhibited significant scavenging
effects against DPPH free radical. The structures of these compounds
were identified and determined as gallic acid (1), (-)-epigallocatechin
3-O-gallate (2), kaempferol (3), kaempferol 7-O-alpha-L-rhamnopyranoside
(4), herbacetin 7-O-alpha-L-rhamnopyranoside, (5) and rhodiolinin
(6) by physico-chemical and spectral evidences.
Am J Clin Nutr. 2000 Aug;72(2 Suppl):624S-36S.
Selected herbals and human exercise performance.
Bucci LR.
Weider Nutrition International, Salt Lake City, UT 84104-4726,
USA.
Herbs have been used throughout history to enhance physical performance,
but scientific scrutiny with controlled clinical trials has only
recently been used to study such effects. The following herbs
are currently used to enhance physical performance regardless
of scientific evidence of effect: Chinese, Korean, and American
ginsengs; Siberian ginseng, mahuang or Chinese ephedra; ashwagandha;
rhodiola; yohimbe; CORDYCEPS: fungus, shilajit or mummio; smilax;
wild oats; Muira puama; suma (ecdysterone); Tribulus terrestris;
saw palmetto berries; beta-sitosterol and other related sterols;
and wild yams (diosgenin). Controlled studies of Asian ginsengs
found improvements in exercise performance when most of the following
conditions were true: use of standardized root extracts, study
duration (>8 wk, daily dose >1 g dried root or equivalent,
large number of subjects, and older subjects. Improvements in
muscular strength, maximal oxygen uptake, work capacity, fuel
homeostasis, serum lactate, heart rate, visual and auditory reaction
times, alertness, and psychomotor skills have also been repeatedly
documented. Siberian ginseng has shown mixed results. Mahuang,
ephedrine, and related alkaloids have not benefited physical performance
except when combined with caffeine. Other herbs remain virtually
untested. Future research on ergogenic effects of herbs should
consider identity and amount of substance or presumed active ingredients
administered, dose response, duration of test period, proper experimental
controls, measurement of psychological and physiologic parameters
(including antioxidant actions), and measurements of performance
pertinent to intended uses.
Zhongguo Zhong Yao Za Zhi. 1996 Nov;21(11):685-7
inside back cover. Hypoglycemic effect of Rhodiola sachalinensis
A. Bor. polysaccharides: comparison of administration in different
ways.
Chem X, Di L, Wu Y, Liu X, Ren Q.
Jilin Provincial Academy of TCM and Materia Medica, Changehun.
When Rhodiola sachalinensis polysaccharides A and B (RSP A and
RSP B) were intraperitoneally injected to mice at dosages of 50
mg/kg and 100 mg/kg, the result showed that RSP B was the effective
hypoglycemic ingredient of Rhodiola sachalinensis. When mice were
administrated in different ways, it was shown that RSP B did not
possess significant hypoglycemic effect through absorption in
the instestines. However, RSP B does possess significant hypoglycemic
effect if administrated subcutaneously, intramuscularly, intraperitoneally
and intravenously.
Eksp Klin Farmakol. 1998 Mar-Apr;61(2):37-40.
The anti-arrhythmia action of an extract
of Rhodiola rosea and of n-tyrosol in models of experimental arrhythmias.
Maimeskulova LA, Maslov LN.
Department of Experimental Cardiology, Russian Academy of Medical
Sciences, Tomsk Research Center, Russia.
A daily 8-day course of Rhodiolae fluidum extract (1 ml/kg; ED50
= 0.43 ml/kg)--a preparation from the group of adaptogens caused
a marked preventive antiarrhythmic effect on models of adrenaline
and CaCl2-induced, but not acontine, arrhythmias. Aglycone--n-tyrosol
demonstrated a lower antiarrhythmic activity (ED50 = 16 mg/kg)
than that of Rhodiola extract.
Patol Fiziol Eksp Ter. 1997 Oct-Dec;(4):22-4.
Effect of Rhodiola rosea on the yield
of mutation alterations and DNA repair in bone marrow cells.
Salikhova RA, Aleksandrova IV, Mazurik VK, Mikhailov VF, Ushenkova
LN, Poroshenko GG.
The study was made of the influence of the Rhodiola rosea extracts
administration on chromosome aberrations, production of cells
with micronuclei and unscheduled DNA synthesis in bone marrow
cells of mice under action of mutagens cyclophosphamide and N-nitroso-N-methylurea
(NMU). It was found that Rhodiola rosea extracts reduce significantly
the yield of cells with the chromosome aberrations and micronuclei
induced by cyclophosphamide in vivo, inhibit unscheduled DNA synthesis
induced by NMU in vitro. It is emphasized that Rhodiola rosea
extracts are antimutagens due to ability to raise the efficiency
of the intracell DNA repair mechanisms.